What This Study Will Provide:
The study involved four major activities in estimating the current size of the sterile filtration market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
# In 2019, Merck (Germany) launched the Stericup Quick Release 500 ml Vacuum Filtration System
# In 2019, Merck (Germany)) expanded its distribution capacity in Gillingham, UK.
# In 2019, Sartorius (Germany) launched Sartolab MultiStation (filtration units).
# In 2018, Pall (US) established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China.
This center is equipped with advanced bioprocessing equipment, including single-use cell culture solutions, cell clarification using acoustic wave technology, chromatography using automated packing techniques, viral clearance, and tangential flow filtration, to serve bioprocess engineering consultancies for China and broader Asia.
Download PDF Brochure@
Growth Boosting Factors:
Growth of this market is driven by factors such as advantages of sterile filters over non-sterile filters, the growing demand for pure water in the end-user market, increasing adoption of single-use technologies, and rising focus on the development of large biopharmaceutical drugs. The manufacturing and use of advanced filters for sterile filtration and the untapped potential in emerging countries offer a significant scope of growth in the sterile filtration market.
Expected Revenue Surge:
The global sterile filtration market size is projected to reach USD 7.6 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 8.2%.
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the sterile filtration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the sterile filtration industry.
Request Sample Pages@
The major companies in the global sterile filtration market are Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), and Parker Hannifin Corp (US).
Merck KGaA accounted for the largest share of the sterile filtration market in 2019. The company has expanded its position as the most profitable technology and solutions supplier in the sterile filtration industry by offering leading-edge products for biotech & pharmaceutical companies and for the advancement of cell and gene therapy. The company also adopts organic strategies such as product launches and expansions to maintain its position in this market.
Danaher Corporation (US) accounted for the second-largest share of the sterile filtration market and it operates in this market through its subsidiary, Pall Corporation. The company’s separation, filtration, and purification technologies revenue have shown a significantly high demand from the biopharmaceutical industry in Western Europe, North America, and other high-growth markets, particularly in the Asia Pacific region. Danaher’s focuses on several organic and inorganic strategies such as product launches, expansions, and partnerships.